S

Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336

Watchlist Manager
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Watchlist
Price: 22.47 CNY 1.63% Market Closed
Market Cap: 13.9B CNY

Wall Street
Price Targets

Price Targets Summary
Sunshine Guojian Pharmaceutical Shanghai Co Ltd

Wall Street analysts forecast Sunshine Guojian Pharmaceutical Shanghai Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 26.46 CNY with a low forecast of 26.2 CNY and a high forecast of 27.24 CNY.

Lowest
Price Target
26.2 CNY
17% Upside
Average
Price Target
26.46 CNY
18% Upside
Highest
Price Target
27.24 CNY
21% Upside
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Competitors:
Price Targets
XNCR
Xencor Inc
67% Upside
TGTX
TG Therapeutics Inc
41% Upside
MCRB
Seres Therapeutics Inc
429% Upside
GNS
Genus PLC
36% Upside
RCEL
AVITA Medical Inc
99% Upside
206650
EuBiologics Co Ltd
34% Upside
OPK
OPKO Health Inc
170% Upside
ALKS
Alkermes Plc
16% Upside

Revenue
Forecast

Revenue Estimate
Sunshine Guojian Pharmaceutical Shanghai Co Ltd

For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is -8%. The projected CAGR for the next 5 years is 23%.

-8%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sunshine Guojian Pharmaceutical Shanghai Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Sunshine Guojian Pharmaceutical Shanghai Co Ltd

For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is -40%. The projected CAGR for the next 4 years is 59%.

-40%
Past Growth
59%
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's stock price target?
Price Target
26.46 CNY

According to Wall Street analysts, the average 1-year price target for Sunshine Guojian Pharmaceutical Shanghai Co Ltd is 26.46 CNY with a low forecast of 26.2 CNY and a high forecast of 27.24 CNY.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Revenue forecast?
Projected CAGR
23%

For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's revenue is -8%. The projected CAGR for the next 5 years is 23%.

What is Sunshine Guojian Pharmaceutical Shanghai Co Ltd's Net Income forecast?
Projected CAGR
59%

For the last 4 years the compound annual growth rate for Sunshine Guojian Pharmaceutical Shanghai Co Ltd's net income is -40%. The projected CAGR for the next 4 years is 59%.

Back to Top